SUNREST

Sunrest Lifescience Share Price

 

 

Start SIP in SUNREST

Start SIP
Sunrest Lifescience live price: ₹37.5. It opened at ₹37 vs previous close ₹37; intraday high/low: ₹38/₹37. The 50 & 200 DMA stand at ₹38.40/₹44.98.

Sunrest Lifescience Performance

  • Today's Low
  • ₹37
  • Today's High
  • ₹38
  • 52 Week Low
  • ₹26
  • 52 Week High
  • ₹54
  • Open Price₹37
  • Previous Close₹37
  • Volume4,800
  • 50 DMA₹38.40
  • 100 DMA₹40.27
  • 200 DMA₹44.98

Investment Returns

  • Over 1 Month -6.62%
  • Over 3 Month -6.62%
  • Over 6 Month -10.97%
  • Over 1 Year -20.03%

Smart Investing Starts Here Start SIP with Sunrest Lifescience for Steady Growth!

Invest Now

Sunrest Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16
  • PEG Ratio
  • -
  • Market Cap Cr
  • 32
  • P/B Ratio
  • 1
  • Average True Range
  • 2.87
  • EPS
  • 2.34
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.1
  • RSI
  • 47.21
  • MFI
  • 35.14

Sunrest Lifescience Financials

Sunrest Lifescience Technicals

EMA & SMA

Current Price
₹37.50
+ 0.5 (1.35%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹38.96
  • 50 Day
  • ₹38.40
  • 100 Day
  • ₹40.27
  • 200 Day
  • ₹44.98

Resistance and Support

37.33 Pivot Speed
  • R3 38.17
  • R2 37.83
  • R1 37.67
  • S1 37.17
  • S2 36.83
  • S3 36.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sunrest Lifescience Ltd has an operating revenue of Rs. 67.42 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 8% is okay, ROE of 12% is good. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 16 indicates it belongs to a strong industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sunrest Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-03-16 Fund Raising & Others (Revised) To consider other business matters. issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.
2026-02-19 Fund Raising & Others To consider other business matters. issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.
2026-02-13 Fund Raising & Others To consider other business matters. issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.
2025-11-13 Quarterly Results
2025-05-30 Audited Results (Revised) issue of equity shares of Rs. 10/- in the ratio of 1:1 @ premium of Rs. 25/-.

Sunrest Lifescience F&O

Sunrest Lifescience Shareholding Pattern

53.5%
34.9%
11.6%

Sunrest Lifescience FAQs

Sunrest Lifescience share price is ₹37 As on 06 April, 2026 | 19:54

The Market Cap of Sunrest Lifescience is ₹32.2 Cr As on 06 April, 2026 | 19:54

The P/E ratio of Sunrest Lifescience is 16 As on 06 April, 2026 | 19:54

The PB ratio of Sunrest Lifescience is 1 As on 06 April, 2026 | 19:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23